Halozyme Therapeutics, Inc.
USD78.60
+1.51 (+1.96%)
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$76.96
Prev. Close
$77.09
Day Low
$76.96
Day High
$78.63
52W Low
$56.05
52W High
$82.26
Market Cap
$9.32B
Volume
1.22M
| 888 |
| $79.28 |
| 9 Jul 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 1,035 | $80.19 |
| 9 Jul 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | Disposed | 1,923 | $12.07 |
| 2 Jul 2026 | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | M-Exempt | Acquired | 10,000 | $0.00 |
| 2 Jul 2026 | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | F-InKind | Disposed | 5,408 | $78.27 |
| 2 Jul 2026 | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | M-Exempt | Disposed | 10,000 | $0.00 |
| 2 Jul 2026 | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | A-Award | Acquired | 16,232 | $0.00 |
| 2 Jul 2026 | RAMSAY DAVID A | EVP, PRESIDENT, DRUG DELIVERY | A-Award | Acquired | 39,823 | $77.01 |
| 2 Jul 2026 | Snellgrove Darren | SVP, Chief Financial Officer | A-Award | Acquired | 41,554 | $0.00 |
| Type |
|---|
| Amount |
|---|
| 8 Apr 2025 | Gilbert Cisneros | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 4 Oct 2024 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 13 Aug 2023 | Daniel Goldman | Daniel Goldman | Sale | $15,001 - $50,000 |
| 13 Jan 2023 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 16 Sept 2022 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 20 Sept 2021 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 5 Nov 2020 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 5 Nov 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |